Literature DB >> 26964686

Early increase in dopamine release in the ipsilateral striatum after unilateral intranigral administration of lactacystin produces spontaneous contralateral rotations in rats.

J Konieczny1, T Lenda2, A Czarnecka2.   

Abstract

Since the discovery of the role of the ubiquitin-proteasome system (UPS) in the pathogenesis of Parkinson's disease, UPS inhibitors, such as lactacystin have been used to investigate the relationship between UPS impairment and degeneration of dopamine (DA) neurons. However, mostly long-term neurotoxic effects of lactacystin have been studied in animal models. Therefore, the aim of our study was to investigate behavioral and biochemical changes related to the DA system during the first week following unilateral intranigral injection of lactacystin to rats. We found that lactacystin produced early spontaneous contralateral rotations which were inhibited by combined administration of DA D1 and D2 receptor antagonists. Simultaneously, an increase in the extracellular level of DA and its metabolites 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanilic acid (HVA) was found in the ipsilateral striatum. In contrast, one week after lesion, when turning behavior was no longer visible, a decrease in the extracellular level of DA, DOPAC and HVA was demonstrated. It was accompanied by a substantial reduction in the tissue levels of DA and its metabolites in the lesioned substantia nigra and striatum. We concluded that unilateral intranigral administration of lactacystin produces an early increase in DA neurotransmission which precedes a decrease in the striatal and nigral tissue DA content. It is manifested by the appearance of spontaneous contralateral rotations and an elevation of the extracellular DA level in the ipsilateral striatum. Since similar behavior was previously observed after intranigral administration of rotenone and MPP(+) but not 6-hydroxydopamine (6-OHDA), it may indicate a common mechanism of action shared by these neurotoxins.
Copyright © 2016 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Parkinson’s disease; dopamine; lactacystin; microdialysis; rotational behavior; substantia nigra

Mesh:

Substances:

Year:  2016        PMID: 26964686     DOI: 10.1016/j.neuroscience.2016.02.072

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  4 in total

Review 1.  The Proteasome Inhibition Model of Parkinson's Disease.

Authors:  Eduard Bentea; Lise Verbruggen; Ann Massie
Journal:  J Parkinsons Dis       Date:  2017       Impact factor: 5.568

Review 2.  Cell Clearing Systems Bridging Neuro-Immunity and Synaptic Plasticity.

Authors:  Fiona Limanaqi; Francesca Biagioni; Carla Letizia Busceti; Larisa Ryskalin; Paola Soldani; Alessandro Frati; Francesco Fornai
Journal:  Int J Mol Sci       Date:  2019-05-04       Impact factor: 5.923

Review 3.  A Sentinel in the Crosstalk Between the Nervous and Immune System: The (Immuno)-Proteasome.

Authors:  Fiona Limanaqi; Francesca Biagioni; Anderson Gaglione; Carla Letizia Busceti; Francesco Fornai
Journal:  Front Immunol       Date:  2019-03-29       Impact factor: 7.561

4.  CerebraLux: a low-cost, open-source, wireless probe for optogenetic stimulation.

Authors:  Robel Dagnew; Yin-Ying Lin; Jerikko Agatep; Michael Cheng; Andrew Jann; Viola Quach; Michelle Monroe; Ganeev Singh; Ani Minasyan; Joshua Hakimian; Theodore Kee; Jesse Cushman; Wendy Walwyn
Journal:  Neurophotonics       Date:  2017-10-11       Impact factor: 3.593

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.